Skip to main content
Shalby Limited logo

Shalby Limited — Investor Relations & Filings

Ticker · SHALBY ISIN · INE597J01018 LEI · 335800RVKD2F29DRCR78 BSE.NS Human health and social work activities
Open in API
Filings indexed 788 across all filing types
Latest filing 2026-05-14 Regulatory Filings
Country IN India
Listing BSE.NS SHALBY

About Shalby Limited

https://www.shalby.org

Shalby Limited is a multi-specialty organization recognized for its expertise in orthopedics and joint replacement surgery. The entity operates a network of facilities offering comprehensive medical services, including cardiology, oncology, neurology, and nephrology. It is distinguished by its high volume of orthopedic procedures and the implementation of the "Zero Technique" for knee replacements, designed to minimize surgical duration and accelerate patient recovery. In addition to clinical care, the organization maintains a presence in the orthopedic implant sector through its manufacturing division, which produces specialized implants and surgical instrumentation. The group focuses on providing tertiary and quaternary care utilizing advanced diagnostic and therapeutic infrastructure to serve a diverse patient base.

Recent filings

Filing Released Lang Actions
Strike-off of Step-down subsidiary Ninegen Lifecare Pvt. Ltd.
Regulatory Filings Classification · 78% confidence The document is a compliance disclosure made under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations. It announces the strike-off of a step-down subsidiary from the Register of Companies. There are no financial statements or substantive analysis, and it is purely a regulatory announcement to the stock exchanges. This matches the criteria for a general regulatory filing under our taxonomy (RNS).
2026-05-14 English
Shalby Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 ,inter alia, to consider and approve audited financial results (standalone ....
Regulatory Filings Classification · 88% confidence The document is a formal intimation to stock exchanges under SEBI regulations announcing the date of a board meeting to consider and approve audited results and dividend recommendation. It is not the meeting materials themselves, nor is it announcing management changes, dividends, or a report publication. This type of regulatory compliance notice falls under the catch-all Regulatory Filings category (RNS).
2026-05-11 English
Updates
Share Issue/Capital Change Classification · 100% confidence The document is an official communication from Shalby Limited to stock exchanges regarding the exercise of employee stock options under the company's Employees Stock Options Scheme – 2021. It details the number of options exercised, the exercise price, the number of shares transferred, and confirms that there is no change in the paid-up equity share capital as the shares were sourced from the secondary market. The document includes disclosures pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, which pertains to material events or information. This is a notification about a share capital-related event (exercise of stock options) rather than a full financial report or earnings release. It does not contain financial statements or management discussion but is a regulatory announcement about a capital change event. Therefore, the appropriate classification is Share Issue/Capital Change (SHA). The document length and content confirm it is not a brief announcement of a report but a substantive regulatory disclosure about capital changes.
2026-05-05 English
Resignation of Independent director
Regulatory Filings
2026-04-17 English
Resignation
Board/Management Information Classification · 100% confidence The document is a formal notification addressed to stock exchanges regarding the resignation of an Independent Director, Mr. Vijay Kishanlal Kedia, from the Board of Directors of Shalby Limited. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosures about changes in the board or management. The content includes details about the resignation, reasons, effective date, and related disclosures. There is no financial data, earnings information, or report publication mentioned. The document is clearly an announcement of a change in senior management/board composition rather than a financial report or other filing type. Therefore, it fits the category of Board/Management Information (MANG). The document length is under 5,000 characters and is a direct announcement, not a report publication announcement or regulatory filing. Confidence is high due to clear regulatory references and content focus.
2026-04-17 English
Updates
Regulatory Filings Classification · 95% confidence The document is a short notice addressed to stock exchanges (NSE and BSE) informing about the receipt of approval for Kidney Transplant services at a hospital unit. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The document is brief (1614 characters) and serves as an intimation or announcement rather than a detailed report or financial filing. It does not contain financial data, management discussion, or audit information. Therefore, it fits best under Regulatory Filings (RNS), which is the category for general regulatory announcements and compliance disclosures that do not fit other specific categories.
2026-04-11 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.